Differential p38 mitogen-activated protein kinase-controlled hypophosphorylation of the retinoblastoma protein induced by nitric oxide in neuroblastoma cells

Free Radical Biology and Medicine

Volumn 44, Issue 3, 2008, Pages 353-366

  González Fernández, Óscar ^a   Jiménez, Amparo ^a   Villalobo, Antonio ^a  

^a CSIC   (Spain)

Author keywords

Cell cycle; Cyclin dependent kinases; Epidermal growth factor receptor; Free radicals; Nitric oxide; p38MAPK; Retinoblastoma protein

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL) 1H IMIDAZOLE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NITRIC OXIDE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NITROSATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; HUMANS; IMIDAZOLES; NEUROBLASTOMA; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 38149088150     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.09.015     Document Type: Article

References (49)

1. Gow A.J., and Ischiropoulos H. Nitric oxide chemistry and cellular signaling. J. Cell. Physiol. 187 (2001) 277-282
2. Davis K.L., Martin E., Turko I.V., and Murad F. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 203-236
3. Villalobo A. Nitric oxide and cell proliferation. FEBS J. 273 (2006) 2329-2344
4. Villalobo A. Enhanced cell proliferation induced by nitric oxide. Dyn. Cell Biol. 1 (2007) 60-64
5. Estrada C., Gómez C., Martín-Nieto J., de Frutos T., Jimémez A., and Villalobo A. Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochem. J. 326 (1997) 369-376
6. Murillo-Carretero M., Ruano M.J., Rodríguez-Matarredona E., Villalobo A., and Estrada C. Antiproliferative effect of nitric oxide on epidermal growth factor-responsive human neuroblastoma cells. J. Neurochem. 83 (2002) 119-131
7. Ruano M.J., Hernández-Hernando S., Jiménez A., Estrada C., and Villalobo A. Nitric oxide-induced epidermal growth factor-dependent phosphorylations in A431 tumour cells. Eur. J. Biochem. 270 (2003) 1828-1837
8. Torroglosa A., Murillo-Carretero M., Romero-Grimaldi C., Matarredona E.R., Campos-Caro A., and Estrada C. Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells 25 (2007) 88-97
9. Browning D.D., Windes N.D., and Ye R.D. Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J. Biol. Chem. 274 (1999) 537-542
10. Huwiller A., and Pfeilschifter J. Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells. J. Exp. Biol. 202 (1999) 655-660
11. Pervin S., Singh R., and Chaudhuri G. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3583-3588
12. Guo K., Andrés V., and Walsh K. Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Circulation 97 (1998) 2066-2072
13. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., and Lüscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101 (2000) 1982-1989
14. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272 (1997) 10050-10057
15. S6k. J. Biol. Chem. 275 (2000) 11389-11396
16. Ciani E., Severi S., Contestabile A., Bartesaghi R., and Contestabile A. Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. J. Cell Sci. 117 (2004) 4727-4737
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Arjona D., Bello M.J., Alonso M.E., González-Gómez P., Aminoso C., Isla A., de Campos J.M., Vaquero J., Gutierrez M., Villalobo A., and Rey J.A. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non homogeneous gene amplification and DNA sequence alterations. Neuropathol. Appl. Neurobiol. 31 (2005) 384-394
19. Gericke A., Munson M., and Ross A.H. Regulation of the PTEN phosphatase. Gene 374 (2006) 1-9
20. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., and Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270 (1995) 7420-7426
21. Johnson J.R., Chu A.K., and Sato-Bigbee C. Possible role of CREB in the stimulation of oligodendrocyte precursor cell proliferation by neurotrophin-3. J. Neurochem. 74 (2000) 1409-1417
22. Arnould T., Vankoningsloo S., Renard P., Houbion A., Ninane N., Demazy C., Remacle J., and Raes M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J. 21 (2002) 53-63
23. Kovach S.J., Price J.A., Shaw C.M., Theodorakis N.G., and McKillop I.H. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma. J. Cell. Physiol. 206 (2006) 411-419
24. Riccio A., Alvania R.S., Lonze B.E., Ramanan N., Kim T., Huang Y., Dawson T.M., Snyder S.H., and Ginty D.D. A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol. Cell 21 (2006) 283-294
25. Delghandi M.P., Johannessen M., and Moens U. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell. Signal. 17 (2005) 1343-1351
26. Möller M.N., Li Q., Lancaster Jr. J.R., and Denicola A. Acceleration of nitric oxide autoxidation and nitrosation by membranes. IUBMB Life 59 (2007) 243-248
27. Morley D., and Keefer L.K. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol. 22 (1993) S3-S9
28. Hrabie J.A., and Keefer L.K. Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives. Chem. Rev. 102 (2002) 1135-1154
29. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57 (1995) 737-769
30. Li H., Sánchez-Torres J., del Carpio A.F., Nogales-González A., Molina-Ortiz P., Moreno M.J., Török K., and Villalobo A. The adaptor Grb7 is a new calmodulin-binding protein: functional implications of the interaction of calmodulin with Grb7. Oncogene 24 (2005) 4206-4219
31. Magenta A., Cenciarelli C., De Santa F., Fuschi P., Martelli F., Caruso M., and Felsani A. MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway. Mol. Cell. Biol. 23 (2003) 2893-2906
32. Zacksenhaus E., Jiang Z., Chung D., Marth J.D., Phillips R.A., and Gallie B.L. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10 (1996) 3051-3064
33. Giacinti C., and Giordano A. RB and cell cycle progression. Oncogene 25 (2006) 5220-5227
34. Guo J., Sheng G., and Warner B.W. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J. Biol. Chem. 280 (2005) 35992-35998
35. Kitagawa M., Higashi H., Jung H.-K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshiba E., Nishimura S., and Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15 (1996) 7060-7069
36. Zarkowska T., and Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272 (1997) 12738-12746
37. Pan W., Sun T., Hoess R., and Grafstrom R. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. Carcinogenesis 19 (1998) 765-769
38. Grafstrom R.H., Pan W., and Hoess R.H. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex. Carcinogenesis 20 (1999) 193-198
39. Fesquet D., Morin N., Doree M., and Devault A. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?. Oncogene 15 (1997) 1303-1307
40. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287 (1999) 821-828
41. Bar-Shai M., and Reznick A.Z. Reactive nitrogen species induce nuclear factor-κB-mediated protein degradation in skeletal muscle cells. Free Radic. Biol. Med. 40 (2006) 2112-2125
42. Uehara T., Nakamura T., Yao D., Shi Z.-Q., Gu Z., Ma Y., Masliah E., Nomura Y., and Lipton S.A. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441 (2006) 513-517
43. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
44. Carballal S., Alvarez B., Turell L., Botti H., Freeman B.A., and Radi R. Sulfenic acid in human serum albumin. Amino Acids 32 (2007) 543-551
45. Vergarajauregui S., San Miguel A., and Puertollano R. Activation of p38 mitogen-activated protein kinase promotes epidermal growth factor receptor internalization. Traffic 7 (2006) 686-698
46. Winograd-Katz S.E., and Levitzki A. Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene 25 (2006) 7381-7390 (Erratum in Oncogene 26:788, 2007)
47. Zwang Y., and Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25 (2006) 4195-4206
48. Sorkin A., and von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev., Mol. Cell Biol. 3 (2002) 600-614
49. Sacksteder C.A., Qian W.-J., Knyushko T.V., Wang H., Chin M.H., Lacan G., Melega W.P., Camp II D.G., Smith R.D., Smith D.J., Squier T.C., and Bigelow D.J. Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. Biochemistry 45 (2006) 8009-8022